| ²é¿´: 1688 | »Ø¸´: 5 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
Îó´³»¯Ñ§ÎÝÒø³æ (³õÈëÎÄ̳)
|
[ÇóÖú]
·Ò룬¹ØÓÚÁÙ´²ÊÔÑéµÄÒ»¾ä»°
|
||
|
The purpose of this randomized, double-blind, placebo-controlled, two-way crossover study was to evaluate the efficacy of OC-000459 in comparison to placebo when patients were challenged in the Vienna Challenge Chamber for 6 h. Ö÷ÒªÊÇÆäÖÐ Vienna Challenge ChamberÔõÑù·Ò룬Çë½ÌÁÙ´²×¨ÒµÈËÊ¿¡£ |
» ²ÂÄãϲ»¶
362Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
334·Ö Ò»Ö¾Ô¸ÎäÀí-080500 ²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸Î人Àí¹¤£¬×Ü·Ö321£¬Ó¢Ò»Êý¶þ£¬ÇóÀÏʦÊÕÁô¡£
ÒѾÓÐ12È˻ظ´
¿¼Ñе÷¼ÁÇóÖú
ÒѾÓÐ6È˻ظ´
263Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
085600 Ò»Ö¾Ô¸9 ×Ü·Ö351 Çóµ÷¼ÁѧУ
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸Î÷½»´ó080500²ÄÁÏѧ˶349
ÒѾÓÐ6È˻ظ´
ÎïÀíѧµ÷¼Á
ÒѾÓÐ4È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
¿¼ÑвÄÁϹ¤³Ì351·Öµ÷¼Á
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
°ïæ·ÒëÒ»¾ä»°
ÒѾÓÐ3È˻ظ´
Çë´óÉñ°ïæ·ÒëÒ»¾ä»°
ÒѾÓÐ5È˻ظ´
·¢½ð±Ò£¬Çó°ïÖú·ÒëÒ»¾ä»°
ÒѾÓÐ11È˻ظ´
Ò»¾äÓ¢ÎÄÇó·Ò룬ºÃÞÖ¿Ú
ÒѾÓÐ1È˻ظ´
Çó·ÒëÒ»¾ä»°£¬forºóµÄÄÚÈÝÔõô·Òë
ÒѾÓÐ3È˻ظ´
ÇóÖúÒ»¾ä»°·Ò룬ͨÐÅÓëÍøÂç
ÒѾÓÐ3È˻ظ´
Çó·ÒëÒ»¾ä»°£¬Òâ´óÀûÓï
ÒѾÓÐ3È˻ظ´
¹ØÓÚspssÊý¾Ý´¦ÀíµÄÒ»¾ä»°£¬Çó·Òë~~~
ÒѾÓÐ2È˻ظ´
Ò»¾ä»°·Òë ÇóÖú
ÒѾÓÐ6È˻ظ´
¼±£¬Çó·ÒëÒ»¾ä»°£¬·Òë´óÅ£ÃÇÇë½ø
ÒѾÓÐ2È˻ظ´
ÇóÖú·ÒëÒ»¾ä»°
ÒѾÓÐ5È˻ظ´
°ïæ·ÒëÒ»¾ä»°£¬¶ÔÎÒÀ´ËµÓеãÄÑÁË¡£¡£¡£¡£¡£
ÒѾÓÐ3È˻ظ´
Ó¢ÎÄÎÄÏ×ÖеÄÒ»¾ä»°£¬ÇóÖú·Ò룬¾ä×ӽṹ·ÖÎö£¡
ÒѾÓÐ7È˻ظ´
¿´²»¶®Ò»¾ä»°ÊÇʲôÒâ˼£¬Çó·Òë
ÒѾÓÐ12È˻ظ´
Ò»¾ä»°·Ò룻I have been on vacation for the last week
ÒѾÓÐ15È˻ظ´
ÇóÖú·ÒëÒ»¾äÓ¢ÎÄ£¬Ò©ÎïÁÙ´²Ñо¿·½ÃæµÄ£¬Ð»Ð»
ÒѾÓÐ6È˻ظ´
ÂÁ²Ä¼·Ñ¹·Òë¡£¾ÍÒ»¾ä»°¡£
ÒѾÓÐ8È˻ظ´
º¬½é´ÊagainstµÄÒ»¾ä»°µÄ·Ò룬ÇóÖú£¡
ÒѾÓÐ15È˻ظ´
·ÒëÒ»¾ä»°£¨Ó¢Ò뺺£©
ÒѾÓÐ13È˻ظ´
´ó¼Ò˵һÏ£¬Ñо¿Éú½×¶ÎÖ÷ҪѧϰÐéÄâÒÇÆ÷£¬¾Íҵǰ¾°ÔõôÑù°¡£¬ÊDz»ÊǾÍÒµ²»Ì«ºÃ°¡
ÒѾÓÐ7È˻ظ´
¡¾×ªÌû¡¿»ÔÈðGCPÅàѵ--ÁÙ´²ÊÔÑéÖÊÁ¿¹ÜÀí¹æ·¶(Ö±ÒëΪÁ¼ºÃµÄÁÙ´²Êµ¼ù£¬GCP)Ŀ¼/ÏÂÔØ
ÒѾÓÐ31È˻ظ´
greenhand_ku
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 57 (³õÖÐÉú)
- ¹ó±ö: 0.087
- ½ð±Ò: 1735.9
- É¢½ð: 1226
- ºì»¨: 23
- ɳ·¢: 1
- Ìû×Ó: 619
- ÔÚÏß: 258Сʱ
- ³æºÅ: 2120375
- ×¢²á: 2012-11-08
- ÐÔ±ð: GG
- רҵ: Óлú¸ß·Ö×Ó²ÄÁÏ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Îó´³»¯Ñ§ÎÝ: ½ð±Ò+5, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2013-11-27 10:12:21
hanches: ½ð±Ò+2, ¸Ðл¹ËÎʵÄÈÈÐÄÓ¦Öú~~ 2013-11-27 11:10:17
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Îó´³»¯Ñ§ÎÝ: ½ð±Ò+5, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2013-11-27 10:12:21
hanches: ½ð±Ò+2, ¸Ðл¹ËÎʵÄÈÈÐÄÓ¦Öú~~ 2013-11-27 11:10:17
|
¼òҪ˵ÏÂVienna Challenge ChamberÒ»´ÊµÄÀ´Àú£¬¹©Â¥Ö÷²Î¿¼£º ¹ýÈ¥¶ÔÓÚ¹ýÃôÐÔ±ÇÑ×µÄÒ©ÎïÆÀ¼ÛÊÔÑéͨ³£ÒÔ¶àµØÇø´ó¹æÄ£µÄ¾ÍÕïÕßÁÙ´²ÊÔÑéΪÖ÷¡£ÌرðÊÇÔÚ»¨·Û֢Ϊ¶ÔÏóµÄÑо¿ÖУ¬Ö»ÄÜÔÚ»¨·Û·ÉÉ¢µÄʱÆÚ½øÐУ¬ÊÔÑé½á¹ûÔںܴó³Ì¶ÈÉÏÊܵ½ÌìÆøºÍÆøÎµÈÒòËØµÄÓ°Ï졣ΪÁ˱ÜÃâÖÖÖÖÒòËØÓ°Ï죬¿ª·¢³öÁËÐí¶à´úÌæÉÏÊö·½·¨µÄ¼¼Êõ£¬»¨·Û±©Â¶ÊÒ¼´ÎªÆäÖÐÖ®Ò»¡£1985ÄêÔڰµØÀûµÄάҲÄÉ´óѧµÄ¶ú±Çºí¿ÆÉèÁ¢ÁËVienna Challenge ChamberµÄÔÐΣ¬Ö®ºóÓÚ1992ÄêÓÖ¿ª·¢³öÁ˾¹ý¸ÄÁ¼ºóµÄVienna Challenge Chamber£¬¼´ÊÀ½ç×î³õµÄ»¨·Û±©Â¶ÊÒ¡£ |

4Â¥2013-11-27 09:35:18
myIDname
ľ³æ (ÖøÃûдÊÖ)
ÈËÃñ´ó»áÌÃÊ×ϯÇå½à¹¤
- SFL-EPI: 17
- Ó¦Öú: 143 (¸ßÖÐÉú)
- ¹ó±ö: 0.295
- ½ð±Ò: 1700.4
- É¢½ð: 1020
- ºì»¨: 30
- ɳ·¢: 2
- Ìû×Ó: 2540
- ÔÚÏß: 414.7Сʱ
- ³æºÅ: 1586017
- ×¢²á: 2012-01-24
- רҵ: ΢/ÄÉ»úеϵͳ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
hanches: ½ð±Ò+2, ÈÈÐÄÓ¦ÖúÓн±~~~ 2013-11-26 09:36:51
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
hanches: ½ð±Ò+2, ÈÈÐÄÓ¦ÖúÓн±~~~ 2013-11-26 09:36:51
|
This paper might be helpful. The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapy http://onlinelibrary.wiley.com/d ... 5.2010.02473.x/full |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : j.1398-9995.2010.02473.x.pdf
2013-11-26 02:43:15, 228.15 K

2Â¥2013-11-26 02:43:33
Îó´³»¯Ñ§ÎÝ
Òø³æ (³õÈëÎÄ̳)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 631.3
- Ìû×Ó: 37
- ÔÚÏß: 25.5Сʱ
- ³æºÅ: 2488999
- ×¢²á: 2013-05-30
- ÐÔ±ð: MM
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
3Â¥2013-11-26 09:21:32
Îó´³»¯Ñ§ÎÝ
Òø³æ (³õÈëÎÄ̳)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 631.3
- Ìû×Ó: 37
- ÔÚÏß: 25.5Сʱ
- ³æºÅ: 2488999
- ×¢²á: 2013-05-30
- ÐÔ±ð: MM
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
5Â¥2013-11-27 10:12:31














»Ø¸´´ËÂ¥